Commercial Excellence In today’s rapidly evolving pharmaceutical landscape, transformation isn’t optional — it’s essential. As new therapies emerge, the demand...
Change Management
Commercial Excellence
The Role of Learning Professionals as Change Agents
Discover how learning professionals become strategic change agents, leveraging targeted frameworks to drive behavior adoption and organizational transformation.
Strategic Execution & Change Management
Time to assess Progress versus the Plan — Transforming Strategic Vision into...
As the first quarter of 2025 concludes, life sciences organizations assess their progress. The 3C's Framework—collaboration, coordination, and...
Change Leadership
Women Leaders in Pharma (2025 Edition): The Work Continues, the Impact Grows
Women leaders in the pharmaceutical industry drive innovation and enhance patient outcomes, yet they remain underrepresented in leadership...
Strategic Execution and Change Management
Building Strategic Account Management Capabilities for Specialty Teams in 2025
The pharmaceutical industry is rapidly evolving as Specialty drugs dominate the market, accounting for 80% of FDA approvals...
Change Leadership
Setting Your 2025 Change Leadership Foundation: Critical Capabilities for the New Year
Prepare for 2025: Master change leadership to navigate healthcare's evolving landscape with reflection, innovation, and readiness for success.
Newsletter
Leaders’ Year-End Playbook: Strategies to Finish Strong and Build Momentum for 2025
As the year winds down, commercial leaders must balance hitting year-end targets while planning for 2025. This period...
Strategic Execution and Change Management
Customer-Centric Transformation: Implementing Account Management Models Around Patient Journeys
In the ever-evolving landscape of healthcare, a seismic shift is underway. Pharmaceutical and life sciences companies are rapidly...
Strategic Execution and Change Management
Navigating the IRA Impact: Change Implementation for Value-Based Account Strategies
The Inflation Reduction Act (IRA) of 2022 represents one of the most significant shifts in U.S. pharmaceutical policy...
Strategic Execution and Change Management
Adapting to IDN Consolidation: Implementing New Account Management Strategies for 2025
The healthcare landscape continues to evolve rapidly, with one of the most significant trends being the ongoing consolidation...
Strategic Execution and Change Management
Future-Proofing Market Access in a Value-Based Healthcare World: Your 2025 Change Roadmap
As the healthcare landscape undergoes seismic shifts, market access leaders in the biopharmaceutical industry find themselves at the...
Strategic Execution and Change Management
Change is coming in 2025: Strategic Resource Allocation for Biopharma Success
If there is one constant every year that companies face, it is Change. Whether it’s new strategic initiatives...